Facebook Instagram Linkedin Youtube
Home Tags ES2B-C001

Tag: ES2B-C001

Expres2ion to raise SEK 60 million

Rights issue takes Expres2ion breast cancer vaccine to phase I

Bent U. Frandsen, CEO ExpreS2ion Biotechnologies

ExpreS2ion CEO: “Compelling preclinical package gives us confidence”

Bent U. Frandsen, CEO ExpreS2ion Biotech talks about the development and the rights issue

ExpreS2ion CEO comments ongoing rights issue

Bent U. Frandsen, CEO ExpreS2ion Biotechnologies

BioStock Investor Pitch: ExpreS2ion Biotechnologies

ExpreS2ion Biotech is looking forward to multiple milestones

Multiple near-term milestones for ExpreS2ion Biotechnologies

Bent U. Frandsen, CEO ExpreS2ion Biotechnologies

ExpreS2ion’s CEO on current development and the rights issue

ExpreS2ion vaccine

Emission avancerar ExpreS2ions vaccinkandidater

ExpreS2ion lab

ExpreS2ions vd om emissionen och vaccinutvecklingen

Bent U. Frandsen

BioStock Investor Pitch: ExpreS2ion Biotechnologies

© BioStock 2024